Biodesix collaborates with Bio-Rad to launch test to detect COVID-19 antibodies
BOULDER -- Biodesix, Inc . announced it has collaborated with California-based Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to launch a blood-based immunoassay-based test that identifies... Read More
Wednesday May 20, 2020 0 comments
Biodesix begins COVID-19 testing, can process 1,000 tests per day in Boulder
BOULDER -- Biodesix, Inc. announced it began SARS-CoV-2 Droplet Digital PCR (ddPCR) testing for the virus that causes COVID-19 and will immediately submit for Emergency Use Authorization from the... Read More
Wednesday April 8, 2020 0 comments
Biodesix strengthens lung nodule testing strategy with Nodify CDT test
BOULDER -- Biodesix, Inc. announced it is extending its blood-based testing portfolio with the release of the Nodify CDT TM test, designed to help physicians identify patients with lung nodules at... Read More
Wednesday March 4, 2020 0 comments
Biodesix partners with Merck, Pfizer on lung cancer proteomic test
BOULDER -- Biodesix, Inc. announced the next phase of the companys biomarker development program with Germany-based Merck and New York-based Pfizer Inc. The companies have completed initial... Read More
Wednesday February 12, 2020 0 comments
Biodesix partners with Streck to support in-vitro diagnostic strategy
BOULDER/LA VISTA, Neb.-- Biodesix, Inc. and Nebraska-based Streck, Inc. announced a Regulatory Cooperation Agreement that will further enable both companies in their pursuit of FDA approval for... Read More
Thursday January 30, 2020 0 comments
Biodesix named Company of the Year by CBSA
BOULDER -- Biodesix, Inc. has been named Company of the Year by the Colorado BioScience Association ( CBSA). The company received the honor at the 16 th Annual CBSA Awards Dinner on Nov. 7. ... Read More
Monday November 11, 2019 0 comments
Biodesix names James Jett new chief medical officer
BOULDER -- Biodesix, Inc . announced the appointment of internationally recognized lung cancer expert James Jett , M.D., as chief medical officer. Dr. Jett joins Steven Springmeyer , M.D.... Read More
Wednesday October 16, 2019 0 comments
Biodesix issued new patent for improved blood specimen collection device
BOULDER -- Biodesix, Inc . announced it has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD). The new device offers improved ease-of-use in blood... Read More
Friday October 4, 2019 0 comments
- 1
- 2
IN Sponsors
Browse
Entrepreneurial by Nature
